These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 6446391)

  • 21. [In vitro antibacterial activity of eight third generation cephalosporins (author's transl)].
    Deforges L; Le Van Thoi J; Soussy CJ; Duval J
    Pathol Biol (Paris); 1982 Jun; 30(6):363-9. PubMed ID: 6810282
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cefoperazone: evaluation of the in vitro activity and an analysis of the disk diffusion test.
    Thornsberry C; Baker CN; Barry AL; Jones RN
    Clin Ther; 1980; 3(Spec Issue):39-45. PubMed ID: 6446397
    [No Abstract]   [Full Text] [Related]  

  • 23. Antimicrobial activity and spectrum of cefoperazone against recent clinical isolates.
    Jones RN; Fuchs PC; Barry AL; Gavan TL; Gerlach EH; Sommers HM
    Clin Ther; 1980; 3(Spec Issue):14-23. PubMed ID: 6446389
    [No Abstract]   [Full Text] [Related]  

  • 24. Comparison of in vitro activity of GR 20263, a novel cephalosporin derivative, with activities of other beta-lactam compounds.
    Wise R; Andrews JM; Bedford KA
    Antimicrob Agents Chemother; 1980 May; 17(5):884-9. PubMed ID: 6772097
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro activities of beta-lactam and aminoglycoside antibiotics. A comparative study of 20 parenterally administered drugs.
    Fass RJ
    Arch Intern Med; 1980 Jun; 140(6):763-8. PubMed ID: 7387270
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synergism between cefazedone and gentamicin in vitro.
    Rudolph V; Reuss K
    Arzneimittelforschung; 1979; 29(2a):396-400. PubMed ID: 114188
    [No Abstract]   [Full Text] [Related]  

  • 27. Activity of azlocillin and mezlocillin against gram-negative organisms: comparison with other penicillins.
    Wise R; Gillett AP; Andrews JM; Bedford KA
    Antimicrob Agents Chemother; 1978 Apr; 13(4):559-65. PubMed ID: 96726
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cefoperazone and cefotiam--two new cephalosporins: an in-vitro comparison.
    Wise R; Andrews JM; Bedford KA
    J Antimicrob Chemother; 1981 Apr; 7(4):343-52. PubMed ID: 6454675
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Activity of HR 756 against Haemophilus influenzae, Bacteroides fragilis and Gram-negative rods.
    Drasar FA; Farrell W; Howard AJ; Hince C; Leung T; Williams JD
    J Antimicrob Chemother; 1978 Sep; 4(5):445-50. PubMed ID: 308506
    [No Abstract]   [Full Text] [Related]  

  • 30. Regression analyses for cefoperazone on Mueller-Hinton agar and DST agar.
    Langmaack H; Daschner F
    Clin Ther; 1980; 3(Spec Issue):123-6. PubMed ID: 6446384
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ceftriaxone: in vitro activity against 410 bacterial isolates compared with cefotaxime.
    Digranes A; Benonisen E; Dibb WL
    Infection; 1982; 10(5):307-9. PubMed ID: 6293978
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro susceptibility of Haemophilus influenzae and neisseria gonorrhoeae to Ro 13-9904 in comparison with other beta-lactam antibiotics.
    Ng WS; Chau PY; Arnold K
    Antimicrob Agents Chemother; 1981 May; 19(5):925-6. PubMed ID: 6271052
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative in vitro activity of moxalactam, cefotaxime, cefoperazone, piperacillin, and aminoglycosides against gram-negative bacilli.
    Kurtz TO; Winston DJ; Hindler JA; Young LS; Hewitt WL; Martin WJ
    Antimicrob Agents Chemother; 1980 Oct; 18(4):645-8. PubMed ID: 6255864
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Third-generation cephalosporins: comparative antibacterial activity against routine clinical isolates.
    Corser CA; Day GJ; Humble MW
    N Z Med J; 1982 Jun; 95(710):414-6. PubMed ID: 6810246
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [In vitro action of moxalactam on hospital bacteria. Results of a multicenter survey].
    Duval J; Deforges L; Bergogne-Berezin E; Chabbert YA; Courtieu AL; Cluzel R; Dabernat H; Witchitz JL
    Sem Hop; 1983 Jun; 59(26):1949-52. PubMed ID: 6310784
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Study of bacterial sensitivity in a Lambaréné hospital (Gabon)].
    Burchard GD; Wolff T
    Med Trop (Mars); 1985; 45(3):265-9. PubMed ID: 3934496
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Susceptibility of anaerobic bacteria to cefoperazone and other beta-lactam antibiotics.
    Jacobus NV; Tally FP; Barza M; Gorbach SL
    Clin Ther; 1980; 3(Spec Issue):34-8. PubMed ID: 6446396
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cefoperazone (T-1551), a new semisynthetic cephalosporin: comparison with cephalothin and gentamicin.
    Jones RN; Fuchs PC; Barry AL; Gavan TL; Sommers HM; Gerlach EH
    Antimicrob Agents Chemother; 1980 Apr; 17(4):743-9. PubMed ID: 6446879
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Cefoperazone--activity in vitro].
    Hejzlar M; Silarová J; Pellar T; Kittnar E; Hájková L; Janatová E; Stastná L; Kotasová M; Puchmayerová M
    Cesk Epidemiol Mikrobiol Imunol; 1983 Mar; 32(2):82-6. PubMed ID: 6220824
    [No Abstract]   [Full Text] [Related]  

  • 40. In vitro evaluation of tigemonam, a novel oral monobactam.
    Tanaka SK; Summerill RA; Minassian BF; Bush K; Visnic DA; Bonner DP; Sykes RB
    Antimicrob Agents Chemother; 1987 Feb; 31(2):219-25. PubMed ID: 3105448
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.